James Gallagher, republicano de California y ex líder de la bancada del Partido Republicano en la Asamblea estatal, ha acusado con frecuencia a los legisladores progresistas del estado de intervenir demasiado en las cuestiones de gobierno. Sin embargo, este año sumó su nombre a una iniciativa legislativa para que las comidas escolares sean más saludables….
The lessons learned and shared by some of the industry’s leaders are exciting, and some clear opportunities are developing. But under the surface, this year, there is something else, and I’m not sure it’s getting enough attention: anxiety. The post Cautious Pessimism – What Isn’t Being Talked About, And What It Means For Healthcare appeared…
Google Cloud is partnering with healthcare organizations including CVS Health, Humana, Highmark Health, Quest Diagnostics and Waystar to deploy agentic AI tools across patient engagement, clinical workflows and revenue cycle management The post CVS, Humana & More Are Turning to Google’s AI Models appeared first on MedCity News.
GSK’s Nuvalent acquisition brings two lead programs, each addressing different targets for non-small cell lung cancer. The Nuvalent lung cancer drugs are under FDA review and if they’re approved, GSK plans to launch both this year. The post GSK Gets a Pair of Near-Commercial Lung Cancer Drugs via $10.6B Nuvalent Acquisition appeared first on MedCity…
San Francisco – KFF announced today that Dr. Dave Ashok Chokshi, a practicing physician and health leader, has joined KFF’s Board of Trustees. Dr. Chokshi is a physician at Bellevue Hospital as well as Sternberg Family Professor of Leadership at the City College of New York.
That is according to the FDA. Nature Reviews Drug Discovery summarizes the progress to date as follows. The FDA’s Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) approved 57 new therapeutic drugs (NTD) in 2024. This is slightly above the average of 53 NTDs per year for 2014–2024,…
Lundbeck says Longboard Pharmaceuticals’ drug, bexicaserin, has potential applications in a range of rare epilepsies. Last month, the biotech began a Phase 3 clinical trial testing the drug in Dravet syndrome. The post Lundbeck’s Neuro-Rare Pipeline Lands Cornerstone Drug via $2.6B Longboard Pharma Acquisition appeared first on MedCity News.
This volume examines unsupported claims about ivermectin; the promotion of unproven “detox” supplements in response to falsehoods about the spike protein from the COVID-19 virus and vaccine; the unsubstantiated claim that byproducts from medication abortion pills contaminate the water supply; and the renewed debate over ADHD diagnoses and treatments.
Maven Clinic has introduced two new features designed to help people get pregnant faster: a personalized menstrual cycle tracker and an at-home semen analysis kit. The post Maven Clinic Launches Cycle Tracker and Male Fertility Tools appeared first on MedCity News.
This post for Health Affairs Forefront examines how the results of the first-ever Medicare drug price negotiations will generate savings for the government and for Medicare beneficiaries, and how candidates’ views on the issue could play a role in the upcoming elections and in the future of government negotiation.